MedTrace Logo

National Prospective Cohort for Monitoring Children With Severe Autoimmune Cytopenia.

NCT04070612 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 122

Last updated 2019-08-28

No results posted yet for this study

Summary

This study aims to study prospectively the clinical and paraclinical evolution and prognostic factors of autoimmune haemolytic anemias, Evans syndromes and chronic immunological thrombocytopenic purpura of children in France.

Conditions

  • Cytopenia
  • Autoimmune Haemolytic Anaemia
  • Thrombocytopenic Purpura, Immune

Interventions

OTHER

Blood sample

A blood sample of 2 times 2 to 5 ml additional maximum

Sponsors & Collaborators

  • University Hospital, Bordeaux

    lead OTHER

Principal Investigators

  • Yves PEREL, Pr · Bordeaux University Hsopital

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-04
Primary Completion
2012-06-08
Completion
2012-06-08

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04070612 on ClinicalTrials.gov